Deep Dive: Deep Dive Into Making Cell and Gene Therapy Practical

Josh Ludwig spoke with CancerNetwork about how ScaleReady, a joint venture between industry leaders launched in January, is equipped to make cell and gene therapy practical and viable. Ludwig touched on the partnership, as well the G-Rex platform, important processes for successful commercialization of cell and gene therapy, and what’s next for ScaleReady.